0001567619-21-011842.txt : 20210608 0001567619-21-011842.hdr.sgml : 20210608 20210608171136 ACCESSION NUMBER: 0001567619-21-011842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210606 FILED AS OF DATE: 20210608 DATE AS OF CHANGE: 20210608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lanfear Dennis M CENTRAL INDEX KEY: 0001420822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 211002988 MAIL ADDRESS: STREET 1: C/O COHERUS BIOSCIENCES, INC. STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2021-06-06 0 0001512762 Coherus BioSciences, Inc. CHRS 0001420822 Lanfear Dennis M COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 1 1 0 0 President & CEO Common Stock 2021-06-06 4 M 0 300000 0.4168 A 493258 D Common Stock 2021-06-08 4 M 0 31054 0.4168 A 524312 D Common Stock 2021-06-08 4 S 0 31054 13.5644 D 493258 D Common Stock 446684 I By Trust Common Stock 86965 I By LLC Stock Option (Right to Buy) 0.4168 2021-06-06 4 M 0 300000 0.00 D 2021-07-17 Common Stock 300000 31054 D Stock Option (Right to Buy) 0.4168 2021-06-08 4 M 0 31054 0.00 D 2021-07-17 Common Stock 31054 0 D These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President. The transaction was executed in multiple trades in prices ranging from $13.55 to $13.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares underlying this option are fully vested and exercisable as of the date hereof. /s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear 2021-06-08